✦ LIBER ✦

Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research

✍ Scribed by Ferdani, Riccardo; Anderson, Carolyn J.

Book ID: 115507890
Publisher: Mary Ann Liebert
Year: 2009
Tongue: English
Weight: 695 KB
Volume: 24
Category: Article
ISSN: 1084-9785
DOI: 10.1089/cbr.2009.0674

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Molecular Imaging o

ChemInform Abstract: Molecular Imaging of Cancer with Copper-64 Radiopharmaceuticals and Positron Emission Tomography (PET)

✍ Monica Shokeen; Carolyn J. Anderson 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 15 KB 👁 2 views

Erratum to: Advances in Hybrid PET/MRI f

Erratum to: Advances in Hybrid PET/MRI for Preclinical and Clinical Cardiac Imaging

✍ Lars Stegger, Christoph Schülke… 📂 Article 📅 2013 🏛 Current Science Inc. 🌐 English ⚖ 55 KB

Nanoparticle delivery systems for cancer

Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research

✍ Susana Patricia Egusquiaguirre; Manuela Igartua; Rosa María Hernández; José Luis 📂 Article 📅 2012 🏛 Springer Milan 🌐 Spanish ⚖ 475 KB

[Advances in Cancer Research] Emerging A

[Advances in Cancer Research] Emerging Applications of Molecular Imaging to Oncology Volume 124 || Clinical Translation of Molecular Imaging Agents Used in PET Studies of Cancer

✍ Kenny, Laura M. 📂 Article 📅 2014 🏛 Elsevier ⚖ 740 KB

[Advances in Pharmacology] Current State

[Advances in Pharmacology] Current State of Alzheimer's Disease Research and Therapeutics Volume 64 || scyllo-Inositol, Preclinical, and Clinical Data for Alzheimer’s Disease

✍ Ma, Keran 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 583 KB

[Recent Results in Cancer Research] Ther

[Recent Results in Cancer Research] Theranostics, Gallium-68, and Other Radionuclides Volume 194 || 68Ga-Radiopharmaceuticals for PET Imaging of Infection and Inflammation

✍ Baum, Richard P.; Rösch, Frank 📂 Article 📅 2012 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 952 KB

This book is based on contributions presented at the 1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy, which examined recent developments in theranostics – the emerging field of molecular targeting of vectors that can be used for both diagnosis and therapy, when modified ac